Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine

Behav Brain Res. 2008 Feb 11;187(1):185-9. doi: 10.1016/j.bbr.2007.09.014. Epub 2007 Sep 16.

Abstract

Although exercise has been known to regulate brain plasticity, its impact on psychostimulant reward and the associated mesolimbic dopamine system remained scarcely explored. A psychostimulant, 3,4-methylenedioxymethamphetamine (MDMA), is currently a worldwide abused drug of choice. We decided to examine the modulating effects of long-term, compulsive treadmill exercise on the hedonic value of MDMA in male C57BL/6J mice. MDMA-induced conditioned place preference (CPP) was used as a behavioral paradigm to indicate the reward efficacy of MDMA. We observed that sedentary control mice all demonstrated reliable MDMA-induced CPP with our conditioning protocol. Interestingly, pre-exposure to a treadmill exercise decreased the later MDMA-induced CPP in a running period-dependent manner. Specifically, mice undergoing a 12-week treadmill running exercise did not exhibit any approaching bias toward the MDMA-associated compartment in this CPP paradigm. Twelve weeks of treadmill running did not alter peripheral metabolism of MDMA 30min following single intraperitoneal injection of MDMA (3mg/kg). We further used microdialysis technique to study the underlying mechanisms for the impaired MDMA reward produced by the12-week exercise pre-exposure. We found that acute MDMA-stimulated dopamine release in nucleus accumbens was abolished in the exercised mice, whereas an obvious elevation of accumbal dopamine release was observed in sedentary control mice. Finally, the 12-week exercise program did not alter the protein levels of primary dopamine receptors, vesicular or membrane transporters in this area. We conclude that the long-term, compulsive exercise is effective in curbing the reward efficacy of MDMA possibly via its direct effect on reversing the MDMA-stimulated dopamine release in nucleus accumbens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Uptake Inhibitors / blood
  • Adrenergic Uptake Inhibitors / pharmacology*
  • Animals
  • Blotting, Western
  • Conditioning, Operant / drug effects
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins / drug effects
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Male
  • Membrane Transport Proteins / drug effects
  • Membrane Transport Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Microdialysis
  • Motor Activity / physiology
  • N-Methyl-3,4-methylenedioxyamphetamine / blood
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism
  • Physical Conditioning, Animal / physiology*
  • Receptors, Dopamine D1 / drug effects
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / metabolism
  • Reward*

Substances

  • Adrenergic Uptake Inhibitors
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Transport Proteins
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Dopamine